 Ruth Napier
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nod2 Signaling Adaptor Protein | 3 | 2025 | 34 | 2.100 |
Why?
| | Th17 Cells | 4 | 2024 | 101 | 1.350 |
Why?
| | CARD Signaling Adaptor Proteins | 2 | 2024 | 22 | 1.040 |
Why?
| | Uveitis | 3 | 2025 | 149 | 0.950 |
Why?
| | Spondylarthritis | 2 | 2024 | 50 | 0.940 |
Why?
| | Arthritis | 3 | 2025 | 96 | 0.890 |
Why?
| | Spondylitis, Ankylosing | 1 | 2024 | 43 | 0.770 |
Why?
| | Mycobacterium tuberculosis | 4 | 2015 | 318 | 0.720 |
Why?
| | Crohn Disease | 1 | 2025 | 260 | 0.710 |
Why?
| | Autoimmune Diseases | 2 | 2022 | 468 | 0.540 |
Why?
| | Imatinib Mesylate | 2 | 2015 | 77 | 0.520 |
Why?
| | T-Lymphocytes | 1 | 2025 | 1996 | 0.510 |
Why?
| | Neutrophils | 3 | 2024 | 1124 | 0.460 |
Why?
| | Francisella | 1 | 2015 | 2 | 0.450 |
Why?
| | Myelopoiesis | 1 | 2015 | 10 | 0.450 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2015 | 49 | 0.430 |
Why?
| | Hereditary Autoinflammatory Diseases | 2 | 2025 | 13 | 0.400 |
Why?
| | Synovitis | 2 | 2025 | 35 | 0.380 |
Why?
| | Tuberculosis | 2 | 2015 | 283 | 0.360 |
Why?
| | Tuberculosis, Multidrug-Resistant | 1 | 2012 | 47 | 0.350 |
Why?
| | Interleukin-17 | 2 | 2024 | 120 | 0.350 |
Why?
| | Sarcoidosis | 2 | 2025 | 163 | 0.340 |
Why?
| | Drug Resistance, Bacterial | 4 | 2015 | 185 | 0.310 |
Why?
| | Cell Differentiation | 2 | 2015 | 2046 | 0.300 |
Why?
| | Piperazines | 1 | 2011 | 375 | 0.290 |
Why?
| | Immunity, Innate | 4 | 2024 | 835 | 0.290 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2011 | 431 | 0.280 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 820 | 0.270 |
Why?
| | Pyrimidines | 1 | 2011 | 530 | 0.270 |
Why?
| | Mutation | 3 | 2025 | 4075 | 0.260 |
Why?
| | Mice | 8 | 2024 | 18329 | 0.240 |
Why?
| | Animals | 10 | 2025 | 38030 | 0.220 |
Why?
| | Bacterial Proteins | 1 | 2011 | 967 | 0.220 |
Why?
| | HLA-B27 Antigen | 1 | 2024 | 16 | 0.210 |
Why?
| | Mucous Membrane | 2 | 2015 | 128 | 0.210 |
Why?
| | Ubiquitin-Activating Enzymes | 1 | 2023 | 20 | 0.200 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2015 | 202 | 0.200 |
Why?
| | Movement Disorders | 1 | 2023 | 69 | 0.190 |
Why?
| | Coculture Techniques | 1 | 2024 | 247 | 0.190 |
Why?
| | Sacroiliitis | 1 | 2022 | 7 | 0.190 |
Why?
| | T-Lymphocyte Subsets | 2 | 2015 | 418 | 0.190 |
Why?
| | Brain Diseases | 1 | 2023 | 155 | 0.180 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2025 | 673 | 0.180 |
Why?
| | Endotoxemia | 1 | 2022 | 86 | 0.180 |
Why?
| | Intellectual Disability | 1 | 2023 | 179 | 0.180 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 69 | 0.170 |
Why?
| | Receptors, CCR7 | 1 | 2020 | 32 | 0.160 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2214 | 0.160 |
Why?
| | Fatty Acids | 2 | 2022 | 457 | 0.160 |
Why?
| | Antitubercular Agents | 2 | 2012 | 208 | 0.150 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2018 | 10 | 0.140 |
Why?
| | beta-Glucans | 1 | 2018 | 16 | 0.140 |
Why?
| | Mice, Inbred C57BL | 3 | 2022 | 5983 | 0.130 |
Why?
| | Mice, Mutant Strains | 1 | 2018 | 302 | 0.130 |
Why?
| | Humans | 11 | 2025 | 145474 | 0.130 |
Why?
| | Immune Tolerance | 1 | 2018 | 385 | 0.120 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1261 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2024 | 2378 | 0.110 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2015 | 15 | 0.110 |
Why?
| | Curcumin | 1 | 2015 | 28 | 0.110 |
Why?
| | Leukocyte Count | 1 | 2015 | 316 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1140 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2018 | 4148 | 0.100 |
Why?
| | Signal Transduction | 1 | 2025 | 5216 | 0.090 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 361 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4560 | 0.090 |
Why?
| | Mice, Knockout | 1 | 2018 | 3124 | 0.080 |
Why?
| | Benzamides | 1 | 2011 | 226 | 0.080 |
Why?
| | Virulence | 1 | 2011 | 278 | 0.080 |
Why?
| | Cytokines | 1 | 2018 | 2067 | 0.080 |
Why?
| | Rhadinovirus | 1 | 2009 | 20 | 0.080 |
Why?
| | Plasma Cells | 1 | 2009 | 79 | 0.070 |
Why?
| | Virus Latency | 1 | 2009 | 90 | 0.070 |
Why?
| | Cell Line | 2 | 2011 | 2823 | 0.070 |
Why?
| | Integration Host Factors | 1 | 2006 | 13 | 0.060 |
Why?
| | Neisseria gonorrhoeae | 1 | 2006 | 29 | 0.060 |
Why?
| | Operon | 1 | 2006 | 67 | 0.060 |
Why?
| | Antibodies, Viral | 1 | 2009 | 674 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1923 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2006 | 337 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2006 | 429 | 0.050 |
Why?
| | Palmitic Acid | 1 | 2022 | 40 | 0.050 |
Why?
| | Drosophila | 1 | 2023 | 164 | 0.050 |
Why?
| | Retinol-Binding Proteins | 1 | 2022 | 17 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2023 | 335 | 0.040 |
Why?
| | Ceramides | 1 | 2022 | 117 | 0.040 |
Why?
| | Male | 3 | 2022 | 72842 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2023 | 213 | 0.040 |
Why?
| | Eye Proteins | 1 | 2022 | 92 | 0.040 |
Why?
| | Transcription Factors | 1 | 2009 | 1734 | 0.040 |
Why?
| | Lymphocytes | 1 | 2022 | 376 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 379 | 0.040 |
Why?
| | Retina | 1 | 2022 | 326 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 858 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 456 | 0.040 |
Why?
| | Autoimmunity | 1 | 2022 | 933 | 0.030 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 1 | 2015 | 9 | 0.030 |
Why?
| | Mycobacterium smegmatis | 1 | 2015 | 14 | 0.030 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2015 | 47 | 0.030 |
Why?
| | Diet | 1 | 2022 | 1277 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2015 | 563 | 0.020 |
Why?
| | Molecular Structure | 1 | 2015 | 486 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2015 | 364 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 334 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2015 | 344 | 0.020 |
Why?
| | Ligands | 1 | 2015 | 665 | 0.020 |
Why?
| | Female | 1 | 2020 | 78844 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 784 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4295 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2015 | 1162 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2878 | 0.020 |
Why?
| | Biological Evolution | 1 | 2015 | 467 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 2028 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1217 | 0.020 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2009 | 17 | 0.020 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 51 | 0.020 |
Why?
| | Virus Activation | 1 | 2009 | 94 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 919 | 0.020 |
Why?
| | Herpesviridae Infections | 1 | 2009 | 148 | 0.020 |
Why?
| | Spleen | 1 | 2009 | 508 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3542 | 0.020 |
Why?
| | Protein Footprinting | 1 | 2006 | 11 | 0.020 |
Why?
| | Base Pairing | 1 | 2006 | 65 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2006 | 190 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2006 | 320 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17291 | 0.010 |
Why?
| | Binding Sites | 1 | 2006 | 1310 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2883 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1246 | 0.010 |
Why?
|
|
Napier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|